Testing KC1086 for advanced solid tumors
Part of Cancer clinical trials.
This study tests a new drug, KC1086, for people with advanced solid tumors that have not responded to standard treatments or for which no standard treatment exists. The goal is to find out if KC1086 is safe and possibly effective, and it may be an option if you are physically active and your organs are healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer is advanced (has spread, come back, or cannot be removed by surgery) and is a solid tumor (not leukemia or lymphoma).
- Standard cancer treatments either did not work, caused bad side effects, or are not available for your type of cancer.
- You are able to be up and about, taking care of yourself (Eastern Cooperative Oncology Group score 0 or 1).
- Your cancer shows at least one tumor that can be measured on scans (per RECIST 1.1).
- Your major organs (bone marrow, kidneys, liver) are working well enough based on blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial studies how a new medicine (KC1036) works and how safe it is for people with advanced solid cancers that have grown despite standard treatments. It may help future patients by showing whether the drug can control cancer in difficult-to-treat cases.
This early-phase study tests whether KC1036 can treat advanced digestive system cancers that have come back or spread after standard treatment. It may help people by shrinking tumors or slowing growth, and it will also check safety and side effects.
This trial tests KC1036 in people with advanced thymoma or thymic carcinoma whose cancer came back or spread after their first standard chemotherapy. It may offer a new treatment option when earlier treatment no longer worked.
This trial tests a new drug called KH801 for people with advanced solid tumors (cancers that have spread) that haven't been helped by other treatments. The goal is to see if it is safe and how well it works.
This study tests a new drug called HC006 for advanced solid tumors that no longer respond to standard treatments. It aims to find a safe dose and see if it helps shrink tumors.
This trial tests a new drug called JSKN027 for people with advanced solid tumors (cancers that have spread) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink tumors.
Hear when a new Advanced Solid Tumors Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.